Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply
Alimentary Pharmacology & Therapeutics · 2026-08 · 64 (3) · 398-399
DOI: 10.1111/apt.70780 ↗At a glance
Editorial in Alimentary Pharmacology & Therapeutics, published online on 2026-06-10. Written by Elyke H Visser and 12 co-authors. Institution: Department of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, the Netherlands. 7 references. The full text is freely available in PubMed Central. Funded by: AbbVie, Celltrion, Dr. Falk Pharma.
Abstract (original language)
Ebda abstract disponibbli.
Authors and institutions
- Department of Gastroenterology & Hepatology, Franciscus Hospital, Rotterdam, the Netherlands.
- Department of Gastroenterology & Hepatology, Erasmus MC, Rotterdam, the Netherlands.
- Department of Public Health, Erasmus MC, Rotterdam, the Netherlands.
- Department of General Practice, Erasmus MC, Rotterdam, the Netherlands.
- Department of Gastroenterology & Hepatology, Amphia Hospital, Breda, the Netherlands.
- Department of Gastroenterology & Hepatology, IJsselland Hospital, Capelle aan de IJssel, the Netherlands.
ORCID profiles: Elyke H Visser
Funding
- AbbVie
- Celltrion
- Dr. Falk Pharma
- Ferring
- Galápagos
- Janssen Pharmaceuticals
- Eli Lilly and Company
- Pfizer
Cite
APA
Visser, E. H., Voshaar, M. A. O., van Linschoten, R. C. A., Bodelier, A. G. L., Fitzpatrick, C., de Jonge, V., Vermeulen, H., Verweij, K. E., van der Wiel, S., van der Horst, D., van der Woude, C. J., West, R. L., & van Noord, D. (2026). Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply. Alimentary Pharmacology & Therapeutics, 64(3), 398-399. https://doi.org/10.1111/apt.70780
Vancouver
Visser EH, Voshaar MAO, van Linschoten RCA, Bodelier AGL, Fitzpatrick C, de Jonge V, et al. Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply. Alimentary Pharmacology & Therapeutics. 2026;64(3):398-399. doi:10.1111/apt.70780
BibTeX
@article{Visser2026,
author = {Visser, Elyke H and Voshaar, Martijn A Oude and van Linschoten, Reinier C A and Bodelier, Alexander G L and Fitzpatrick, Claire and de Jonge, Vincent and Vermeulen, Hestia and Verweij, K Evelyne and van der Wiel, Sanne and van der Horst, Daniëlle and van der Woude, C Janneke and West, Rachel L and van Noord, Desiree},
title = {Editorial: Inflammatory Bowel Disease Care Pathways—Improving Quality, but Not at Increased Cost. Authors' Reply},
journal = {Alimentary Pharmacology & Therapeutics},
year = {2026},
volume = {64},
number = {3},
pages = {398--399},
doi = {10.1111/apt.70780}
}
EUVIMED